PSMA-negative prostate cancer and the continued value of choline-PET/CT

Alberts, Ian; Sachpekidis, Christos; Fech, Viktor; Rominger, Axel; Afshar-Oromieh, Ali (2020). PSMA-negative prostate cancer and the continued value of choline-PET/CT. Nuklearmedizin, 59(1), pp. 33-34. Thieme 10.1055/a-1044-1855

[img] Text
Alberts_PSMA-negative prostate cancer and the continued value of choline PETCT.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

Owing to their superior uptake and higher detection rate, PSMA-labelled radioligands have largely replaced choline in routine clinical imaging of recurrent prostate cancer (PCa). Nevertheless, even at high PSA values, a small number of patients can present with PSMA negative prostate cancer (PC) lesions. For such patients choline PET continues to play an important role.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine

UniBE Contributor:

Alberts, Ian Leigh; Sachpekidis, Christos; Fech, Viktor; Rominger, Axel Oliver and Afshar Oromieh, Ali

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0029-5566

Publisher:

Thieme

Language:

Multilingual

Submitter:

Sabine Lanz

Date Deposited:

18 Dec 2019 10:28

Last Modified:

09 Mar 2020 08:09

Publisher DOI:

10.1055/a-1044-1855

PubMed ID:

31766065

BORIS DOI:

10.7892/boris.136797

URI:

https://boris.unibe.ch/id/eprint/136797

Actions (login required)

Edit item Edit item
Provide Feedback